COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes

Table 1

Baseline parameters between COVID-19 and cancer patients.

Variables
Sex		≤0.001
Cancer
Male	152
Female	66
COVID-19
Male	86
Female	81
Age		0.646
Cancer
<60	120
≥60	98
COVID-19
<60	88
≥60	79
COVID-19		≤0.001
Nonsevere	116
Severe	51
Cancer type		0.104
Respiratory system	121
Nonrespiratory system	97
Cancer distant metastasis		≤0.001
M0	96
M1	29
Unknown	93
IL-2		0.906
Cancer
Normal	195
High	23
COVID-19
Normal	150
High	17
IL-4		0.156
Cancer
Normal	198
High	20
COVID-19
Normal	144
High	23
IL-6		≤0.001
Cancer
Normal	48
High	170
COVID-19
Normal	83
High	84
IL-10		≤0.001
Cancer
Normal	188
High	30
COVID-19
Normal	118
High	49
IFN-γ		0.105
Cancer
Normal	218
High	0
COVID-19
Normal	165
High	2
TNF-α		0.850
Cancer
Normal	217
High	1
COVID-19
Normal	166
High	1
		0.028
Cancer
Normal	102
Low	116
COVID-19
Normal	97
Low	70
		0.003
Cancer
Normal	126
Low	92
COVID-19
Normal	121
Low	46
		0.109
Cancer
Normal	79
Low	139
COVID-19
Normal	74
Low	93
4/8 ratio		0.014
Cancer
Normal	110
High	56
Low	52
COVID-19
Normal	90
High	56
Low	21
		0.019
Cancer
Normal	35
Low	183
COVID-19
Normal	43
Low	124
		0.403
Cancer
Normal	102
Low	116
COVID-19
Normal	71
Low	96
LYM		0.625
Cancer
Normal	111
High	1
Low	106
COVID-19
Normal	89
Low	78
NEU		0.260
Cancer
Normal	144
High	53
Low	21
COVID-19
Normal	122
High	35
Low	10
MONO		0.268
Cancer
Normal	148
High	65
Low	5
COVID-19
Normal	126
High	38
Low	3

Abbreviations: M: metastasis; : absolute count of cells; : absolute count of cells; : absolute count of cells; : absolute count of cells; : absolute count of cells; LYM: lymphocyte; NEU: neutrophil; MONO: monocyte.